Radiosurgery of Ganglion StELlatum In Patients With REFractory Angina Pectoris
NCT05600751 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10
Last updated 2024-01-18
Summary
The core hypothesis to be tested is that the radiosurgery of stellate ganglion (left one or both if left-sided without full relief of symptoms) is an effective therapy of refractory angina pectoris in patients with no other therapeutic options - proof of concept study.
Conditions
- Coronary Artery Disease
- Angina Pectoris
- Myocardial Ischemia
Interventions
- PROCEDURE
-
Radiosurgery of ganglion stellatum
Patients will undergo radiosurgery of ganglion stellatum (left one or both)
Sponsors & Collaborators
-
Nemocnice AGEL Trinec-Podlesi a.s.
collaborator OTHER -
University Hospital Ostrava
lead OTHER
Principal Investigators
-
Jakub Cvek, Assoc.Prof.,MD,Ing.,PhD · University Hospital Ostrava
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-01-01
- Primary Completion
- 2024-12-31
- Completion
- 2024-12-31
Countries
- Czechia
Study Locations
More Related Trials
-
Cardiopulmonary Toxicity of Thoracic Radiotherapy
NCT03978377 ·Status: RECRUITING
-
Stereotactic Body Radiation Therapy for Inoperable Non-metastasized Pancreatic Adenocarcinoma
NCT06691425 ·Status: RECRUITING ·Phase: NA
-
Cardiac Tumors Interventional (Radio Frequency/Laser Ablation)Therapy
NCT02815553 ·Status: UNKNOWN ·Phase: NA
-
Stereotactic Body Radiotherapy and Radiofrequency Ablation for Lung Tumors Near Central Airways
NCT01051037 ·Status: COMPLETED ·Phase: NA
-
Fractionated Stereotactic Radiotherapy in Patients With Acromegaly
NCT00934271 ·Status: COMPLETED
-
Radiation-induced Cardiac Toxicity After Non-small Cell Lung Cancer Radiotherapy
NCT04867564 ·Status: UNKNOWN
-
Study of Stereotactic Body Radiation Therapy Using Tomotherapy for Metastatic Tumors to the Liver
NCT01030757 ·Status: TERMINATED ·Phase: PHASE2
-
Combined Beta- Plus Auger Electron Therapy Using a Novel Somatostatin Receptor Subtype 2 Antagonist Labelled With Terbium-161 (161Tb-DOTA-LM3)
NCT05359146 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Stereotactic Body Radiotherapy for Liver Tumors
NCT01347333 ·Status: COMPLETED ·Phase: NA
-
Stereotactic Volumetric Radiotherapy in Prostate Cancer
NCT02423889 ·Status: COMPLETED ·Phase: PHASE2
-
A Study For Using Radiosurgery On Limited Metastases
NCT00178399 ·Status: COMPLETED ·Phase: NA
-
Follow-up of Pulmonary Radiotoxicity for Bronchopulmonary Cancer.
NCT03931356 ·Status: COMPLETED
-
Stereotactic Radiotherapy for Brain Metastases
NCT03286023 ·Status: UNKNOWN
-
Consolidation Conventional Radiotherapy + Stereotactic Body Radiotherapy at 3 Months After First-line Chemotherapy in Stage IV Oligometastatic Non-small Cell Lung Cancer
NCT04758481 ·Status: UNKNOWN ·Phase: NA
-
Breast Stereotactic Radiotherapy to Primary Tumors in Metastatic Patients
NCT05229575 ·Status: UNKNOWN ·Phase: NA
-
Stereotactic Hypofractionated Accelerated Radiotherapy Post-Prostatectomy
NCT02976402 ·Status: UNKNOWN ·Phase: PHASE1
-
Efficacy of Magnetic Resonance-guided High Intensity Focused Ultrasound for the Ablation of Breast Cancer
NCT03560102 ·Status: TERMINATED ·Phase: NA
-
Adjuvant Radiotherapy for Stage II/III Thymoma After Complete Resection
NCT02633553 ·Status: RECRUITING ·Phase: NA
-
Functional Imaging of Treatment Effects: A Companion Protocol to a Study of Extracranial Stereotactic Radioablation in Early Stage Non-Small Cell Lung Cancer
NCT00246116 ·Status: COMPLETED ·Phase: NA
-
Palliative Short Course Radiotherapy for Advanced Thoracic Cancer
NCT03465553 ·Status: COMPLETED ·Phase: NA
-
Stereotactic Body Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed By Surgery
NCT00551369 ·Status: COMPLETED ·Phase: PHASE2
-
Non-interventional Observational Study of Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Cancer
NCT02228356 ·Status: UNKNOWN
-
Stereotactic Ablative Radiotherapy for Comprehensive Treatment of 4-10 Oligometastatic Tumors
NCT03721341 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Prediction of the Effectiveness of Hypofractionated Radiation Therapy in Early Stage Lung Cancer by Bio-imaging and Biomarkers
NCT01138748 ·Status: TERMINATED ·Phase: PHASE2
-
Involved Field Radiotherapy for Non-gastric Marginal Zone Lymphoma
NCT00377195 ·Status: UNKNOWN ·Phase: PHASE2